These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18836797)

  • 1. Postoperative adjuvant treatments for biliary tract cancer.
    Furuse J
    J Hepatobiliary Pancreat Surg; 2008; 15(5):463-7. PubMed ID: 18836797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chemotherapy in treatments for biliary tract cancer.
    Furuse J; Kasuga A; Takasu A; Kitamura H; Nagashima F
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):337-41. PubMed ID: 22456744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.
    Konishi M
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):301-5. PubMed ID: 22262202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment and adjuvant chemotherapy for patients with biliary tract cancer: single institution experience of 100 patients.
    Harada N; Shirabe K; Yoshizumi T; Ikegami T; Uchiyama H; Soejima Y; Yamashita Y; Saeki H; Oki E; Kawanaka H; Morita M; Ikeda T; Matsuura H; Okadome K; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):539-48. PubMed ID: 24693682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
    Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
    Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial).
    Okusaka T; Ueno M; Sato T; Heike Y
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):314-8. PubMed ID: 22273718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.
    Siebenhüner AR; Seifert H; Bachmann H; Seifert B; Winder T; Feilchenfeldt J; Breitenstein S; Clavien PA; Stupp R; Knuth A; Pestalozzi B; Samaras P
    BMC Cancer; 2018 Jan; 18(1):72. PubMed ID: 29325521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.
    Edeline J; Benabdelghani M; Bertaut A; Watelet J; Hammel P; Joly JP; Boudjema K; Fartoux L; Bouhier-Leporrier K; Jouve JL; Faroux R; Guerin-Meyer V; Kurtz JE; Assénat E; Seitz JF; Baumgaertner I; Tougeron D; de la Fouchardière C; Lombard-Bohas C; Boucher E; Stanbury T; Louvet C; Malka D; Phelip JM
    J Clin Oncol; 2019 Mar; 37(8):658-667. PubMed ID: 30707660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant treatment of biliary tract cancers: Who and how?].
    Edeline J
    Bull Cancer; 2020 Jan; 107(1):48-53. PubMed ID: 31980143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Kobayashi H; Kondo N; Nakagawa N; Sueda T
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):306-13. PubMed ID: 22270151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
    Lamarca A; Edeline J; McNamara MG; Hubner RA; Nagino M; Bridgewater J; Primrose J; Valle JW
    Cancer Treat Rev; 2020 Mar; 84():101936. PubMed ID: 31986437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for biliary tract cancer in Japan.
    Okusaka T
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):51-3. PubMed ID: 12577234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.
    Takahara T; Nitta H; Hasegawa Y; Itou N; Takahashi M; Nishizuka S; Wakabayashi G
    Cancer Chemother Pharmacol; 2012 May; 69(5):1127-33. PubMed ID: 22207029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakamura H; Nakashima A; Sueda T
    Ann Surg; 2009 Dec; 250(6):950-6. PubMed ID: 19953713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202).
    Yanagimoto H; Toyokawa H; Sakai D; Wada H; Satoi S; Yamamoto T; Nagano H; Toyoda M; Ajiki T; Satake H; Tsuji A; Miyamoto A; Tsujie M; Takemura S; Yanagihara K; Ioka T
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):461-468. PubMed ID: 29305639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for pancreatic and biliary tract cancer: the United Kingdom experience.
    Pereira S
    J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S48-51. PubMed ID: 23055216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of gemcitabine in biliary tract carcinoma.
    Scheithauer W
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):40-5. PubMed ID: 12577232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer.
    Yamanaka K; Hatano E; Kanai M; Tanaka S; Yamamoto K; Narita M; Nagata H; Ishii T; Machimoto T; Taura K; Uemoto S
    Int J Clin Oncol; 2014; 19(3):485-9. PubMed ID: 23765238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for chemotherapy of biliary tract and ampullary carcinomas.
    Furuse J; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Kondo S; Saito H; Tsuyuguchi T; Hirata K; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
    J Hepatobiliary Pancreat Surg; 2008; 15(1):55-62. PubMed ID: 18274844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.